Skip to main content
. 2021 Aug 25;9(9):948. doi: 10.3390/vaccines9090948

Table 2.

COVD-19-related anamnesis and influenza vaccine experience of participating Czech university students (April–June 2021, n = 1351).

Outcome Female Male Sig. Czech Non-Czech Sig. HCS Non-HCS Sig. Total
COVID-19 Infection 257 (28.5%) 141 (32.1%) 0.169 347 (30.4%) 53 (25.4%) 0.143 169 (30.8%) 231 (28.8%) 0.434 400 (29.6%)
Providing Care 303 (33.6%) 135 (30.8%) 0.304 387 (33.9%) 55 (26.3%) 0.032 211 (38.4%) 231 (28.8%) <0.001 442 (32.7%)
Knowing Patient 893 (98.9%) 434 (98.9%) 0.959 1128 (98.8%) 207 (99%) 0.741 542 (98.7%) 793 (98.9%) 0.799 1335 (98.8%)
Knowing Dead 329 (36.4%) 141 (32.1%) 0.120 404 (35.4%) 68 (32.5%) 0.428 188 (34.2%) 284 (35.4%) 0.658 472 (34.9%)
Flu Vaccine 177 (19.6%) 100 (22.8%) 0.177 214 (18.7%) 66 (31.6%) <0.001 133 (24.2%) 147 (18.3%) 0.009 280 (20.7%)
Recent Flu Vaccine 78 (44.6%) 46 (46%) 0.819 98 (46%) 27 (41.5%) 0.526 84 (63.6%) 41 (28.1%) <0.001 125 (45%)

HCS = Healthcare Students. Non-HCS = Non-Healthcare Students. Chi-squared test (χ2) was used with a significance level (Sig.) of ≤0.05.